TAM
RGNX icon

Tocqueville Asset Management’s Regenxbio RGNX Stock Holding History

Tocqueville Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,545
Closed -$447K – 764
2019
Q3 		$447K Buy
12,545
+25
+0.2% +$1.01K 0.01% 587
2019
Q2 		$643K Hold
12,520
– – 0.01% 546
2019
Q1 		$718K Buy
12,520
+6,275
+100% +$311K 0.01% 527
2018
Q4 		$262K Sell
6,245
-6,000
-49% -$352K ﹤0.01% 651
2018
Q3 		$924K Buy
12,245
+1,570
+15% +$113K 0.01% 515
2018
Q2 		$766K Buy
+10,675
New +$510K 0.01% 545

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Tocqueville Asset Management's RGNX Position: Q4 2019 in Review

Tocqueville Asset Management sold out of Regenxbio (RGNX) in Q4 2019, closing a stake of 12,545 shares — an estimated $447K sold.

Tocqueville Asset Management first reported a position in RGNX in Q2 2018 and held it in 6 quarters. The position peaked at $924K in Q3 2018. 187 funds tracked by Wall St. Rank hold RGNX as of Q4 2019.

  • Tocqueville Asset Management reported no remaining Regenxbio position as of Q4 2019 after selling out during the quarter.
  • Tocqueville Asset Management sold 12,545 Regenxbio shares in Q4 2019, an estimated $447K.
  • Tocqueville Asset Management first reported a position in Regenxbio in Q2 2018 and held it in 6 quarters.
  • Tocqueville Asset Management's Regenxbio position peaked at $924K in Q3 2018.
  • 187 funds tracked by Wall St. Rank held Regenxbio as of Q4 2019.

Based on Tocqueville Asset Management's 13F filing for Q4 2019, filed 14 Jan 2020.